1.会计核算不规范。一是2021年子公司海南融盛弘科技有限公司将部分广告费用支出 错误计入无形资产。二是2023年子公司西藏康域药业有限公司(以下简称西藏康域)部分医 疗器械销售，在未发生实物流转，控制权未转移给客户的情况下即确认收入，且发生期后 退货。三是2023年子公司成都远泓矿泉水有限公司(存在业绩承诺)少量销售费用核算至其 他子公司，影响业绩考核测算精准性。上述情形不符合《企业会计准则第6号——无形资产》 第十二条第二款、《企业会计准则第14号——收入》第十三条第一款第三项及第四项、《企 业会计准则——基本准则》第五条相关规定。 证券代码：000790 证券简称：华神科技 公告编号：2025-019 成都华神科技集团股份有限公司 关于收到中国证券监督管理委员会四川监管局 行政监管措施决定书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 成都华神科技集团股份有限公司（以下简称"公司"）及相关责任人于近日收到中国证 券监督管理委员会四川监管局（以下简称"四川证监局"）出具的《关于对成都华神科技集 团股份有限公司采取责令改正并对黄明良等相关责任人采取 ...

Core Viewpoint - The company is facing challenges in its financial performance for 2024, with a significant decline in revenue and net profit, primarily due to strategic business adjustments and ongoing project developments [2]. Group 1: Financial Performance - In 2024, the company's operating revenue decreased by 13.89% year-on-year, resulting in a net profit loss [2]. - The decline in revenue and profit is attributed to the active contraction of the construction steel structure business, the ongoing trial production of the Shandong Lingkai project, and increased financial costs due to higher bank financing [2]. Group 2: Market Position and Competitive Advantage - The company has a strong market competitiveness and brand recognition in the pharmaceutical and health beverage sectors, with several products included in the medical insurance catalog [3]. - The company's health business segment, Huashen Blue Light, possesses rare mineral water resources, with its Biri 59 product having a silicate content of 59.99 mg/L, significantly exceeding national standards [3]. Group 3: Research and Development Focus - The company plans to focus on the in-depth exploration and secondary development of major traditional Chinese medicine products, particularly the Sanqi Tongshu capsules and Biyuan Shu, to enhance product application range and efficacy [4]. Group 4: Response to Industry Policy Changes - The company is closely monitoring changes in medical insurance payment reforms and drug procurement policies, aiming to enhance its risk resistance through market expansion and product quality management [5]. Group 5: New Market Expansion - The company is considering international market expansion based on its core traditional Chinese medicine products, which are recognized in the German Pharmacopoeia, while also planning to develop related health products and services [6]. Group 6: Asset Restructuring and Strategic Investment - The company will prudently evaluate asset restructuring and strategic investment opportunities based on its development strategy and market conditions [7].

Group 1 - Yitong Century won a bid for a communication engineering construction service project from China Mobile, with a total bid amount of 228 million yuan (including tax) [1] - Zhiyuan New Energy plans to repurchase shares worth between 33 million and 66 million yuan, with a maximum repurchase price of 22.00 yuan per share [1] - GAC Group reported April automobile sales of 116,400 units, a year-on-year decrease of 12.66% [2] - JAC Motors reported April automobile sales of 30,764 units, a year-on-year decrease of 3.55% [3] Group 2 - Fosun Pharma's subsidiary received FDA approval for a clinical trial of a live biotherapeutic product aimed at treating androgenetic alopecia [4] - Liangxin Co. obtained multiple patent certificates, including 2 invention patents and 32 utility model patents [5] - Sainuo Medical's two products received medical device registration certificates in Mexico and Ecuador [5] - Huayu Pharmaceutical's two products received marketing approvals in France and Spain [6] Group 3 - Shengnong Development reported April sales revenue of 1.533 billion yuan, a year-on-year increase of 0.68% [6] - Hasi Lian's potassium chloride and sodium chloride injection passed the consistency evaluation [7] - Shapuaisi received approval for a supplemental application for levofloxacin eye drops [9] - Tianyu Biological reported April sales revenue of 59.32 million yuan from pig sales [10] Group 4 - *ST Weihai was pre-awarded a project worth 108 million yuan [12] - Luoniushan reported April sales revenue of 125 million yuan from pig sales, a year-on-year increase of 12.72% [13] - Minhe Co. reported April sales revenue of 68.30 million yuan from chick sales, a year-on-year increase of 0.51% [14] Group 5 - Double Ring Technology's application for a specific stock issuance was approved by the Shenzhen Stock Exchange [15] - Hualu Hengsheng plans to repurchase shares worth between 200 million and 300 million yuan [16] - Baolong Technology plans to repurchase shares worth between 100 million and 200 million yuan [17] Group 6 - Huasheng Technology's subsidiary plans to sell shares of a company for 200 million yuan [24] - *ST Gengxing's controlling shareholder plans to increase holdings worth between 30 million and 60 million yuan [25] - Ruihuatai's shareholder plans to reduce holdings by up to 1% of the company's shares [26] Group 7 - Foton Motor reported April commercial vehicle sales of 54,816 units, a year-on-year increase of 21.63% [20] - China Merchants Bank plans to invest 15 billion yuan to establish a financial asset investment company [22] - Jinchengxin plans to invest approximately 231 million USD in the Alacran copper-gold-silver mine project [23] Group 8 - Zhongji United's controlling shareholder plans to reduce holdings by up to 2% of the company's shares [30] - Ningbo Huaxiang signed a strategic cooperation agreement to strengthen collaboration in various areas [31] - SMIC reported a net profit of 1.356 billion yuan for Q1 2025, a year-on-year increase of 166.5% [32] Group 9 - FAW Fuwi received a project notification to develop seat products for a luxury brand, with a total sales amount expected to be 1.39 billion yuan [33] - Huakang Clean won a bid for a purification project worth 64.425 million yuan [34] - Lihua Co. reported April sales revenue of 1.125 billion yuan from chicken sales [35]

关于召开 2024年度网上业绩说明会的公告 重要内容提示： 证券代码：000790 证券简称：华神科技 公告编号：2025-018 成都华神科技集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 二、参加人员 公司董事长、总裁黄明良先生，独立董事毛道维先生，独立董事陈旭东先 生，独立董事朱超溪女士，副总裁兼财务总监李俊先生，董事会秘书宁潞宏先 生（如遇特殊情况，出席人员将酌情调整）。 三、投资者参加方式 投资者可于2025年05月15日（星期四）15:00-16:30通过网址https://eseb.cn/1 o6IXOaVoCk或使用微信扫描下方小程序码即可进入参与互动交流。投资者可于 2025年05月15日前进行会前提问，公司将通过本次业绩说明会，在信息披露允 许范围内就投资者普遍关注的问题进行回答。 成都华神科技集团股份有限公司（简称"公司"）已于 2025 年 4 月 29 日在 巨潮资讯网（www.cninfo.com.cn）披露了《2024 年年度报告》及其摘要。为方 便广大投资者更加全面深入地了解公司发展战略、经营业绩等情况，公司定 ...

Core Insights - The behavior of margin traders has attracted significant market attention, with investors hoping to capture investment opportunities from their activities [1] Group 1: Margin Trading Data - On May 8, a total of 3,663 stocks received margin buying funds, with the top three stocks being Xinyi Technology (¥1.425 billion), Zhongji Xuchuang (¥1.053 billion), and Shenghong Technology (¥807 million) [1] - The table lists stocks with the highest margin buying amounts, including Tiancheng Technology (¥15.75 million), Xingqiu Graphite (¥8.83 million), and Lianyu Co. (¥15.27 million), showing their respective transaction amounts and margin buying ratios [1] - Margin buying accounted for significant percentages of total transaction amounts for various stocks, with Tiancheng Technology at 28.65%, Xingqiu Graphite at 28.51%, and Lianyu Co. at 28.15% [1] Group 2: Stock Performance - The price changes of stocks with high margin buying varied, with some stocks experiencing gains, such as Tiancheng Technology (1.47%) and Xingqiu Graphite (2.39%), while others like Fuliwang saw a decline (-3.29%) [1][2] - The data indicates that margin buying can correlate with stock performance, as seen in the fluctuations of the stocks listed [1][2]

华神科技：子公司拟2亿元出售参股公司股权 华神科技(000790)公告，子公司星瑞药业拟将持有的上海凌凯科技股份有限公司（简称"上海凌凯"） 5.4019%股份以2亿元转让给陆茜，本次交易完成后，星瑞药业不再持有上海凌凯股份。 招商银行：拟出资150亿元全资发起设立金融资产投资公司 招商银行(600036)公告，公司拟出资150亿元，全资发起设立金融资产投资公司。本次设立的金融资 产投资公司初始注册资本为人民币150亿元，由公司作为投资主体根据《金融资产投资公司管理办法 （试行）》，使用自有资金直接投资设立。成功设立后，本次设立的金融资产投资公司将成为公司全 资一级子公司，具体业务范围以金融监督管理机构批复为准。本次设立金融资产投资公司符合公司业 务发展需要，有助于丰富公司综合化经营牌照，完善投商行一体化经营，提升服务实体经济能力。本 次投资不会对公司的财务状况或经营成果产生重大影响。 2025.05. 08 5月8日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 金诚信：拟投资约2.31亿美元建设Alacran铜金银矿项目 金诚信(603979)公告，鉴 ...

Investment Announcements - Jincheng intends to invest approximately $231 million in the Alacran copper-gold-silver mine project, following the acquisition of a 5% stake in CMH Colombia S.A.S., which will allow it to hold a 55% stake and control the project development [3] - Huasheng Technology's subsidiary plans to sell a 5.4019% stake in Shanghai Lingkai Technology Co., Ltd. for 200 million yuan, resulting in the subsidiary no longer holding shares in the company [4] - China Merchants Bank plans to invest 15 billion yuan to establish a wholly-owned financial asset investment company, which will enhance its integrated operations and service capabilities [5] Performance Reports - Huahong's Q1 revenue reached 3.913 billion yuan, a year-on-year increase of 18.66%, while net profit dropped by 89.73% to 22.76 million yuan, indicating challenges in the semiconductor industry due to international and policy changes [7] - King Long Automobile reported a production of 4,361 buses in April, a decrease of 5.79% year-on-year, with sales of 3,611 buses, down 3.91% [8] - Zhengbang Technology's April pig sales reached 609,800 heads, with revenue of 738 million yuan, showing a significant year-on-year increase of 174.29% [9] - Sunac China achieved a contract sales amount of approximately 1.1 billion yuan in April, with a cumulative total of 11.2 billion yuan by the end of April [11] - *ST Aonong reported a pig sales volume of 132,800 heads in April, a year-on-year decrease of 14.42% [12] Major Contracts - Pinggao Electric won contracts totaling approximately 1.751 billion yuan from the State Grid, representing 14.12% of its 2024 revenue [14] - State Grid Information Technology's subsidiaries secured contracts worth 477 million yuan, positively impacting future performance [15] - Dongfang Tower won a procurement project from the State Grid worth about 100 million yuan, accounting for 2.39% of its 2024 revenue [16] - Jiaojian Co. won a construction project worth approximately 704 million yuan, with a project duration of 870 days, representing 8.43% of its 2024 revenue [17] Shareholding Changes - Ruihua Tai's shareholder plans to reduce holdings by up to 1% of the company's shares [19] - *ST Gengxing's controlling shareholder intends to increase holdings between 30 million and 60 million yuan [20] - Lexin Technology's shareholder plans to reduce holdings by up to 1.2032% of the company's shares [22] Share Buybacks - Sichuan Meifeng plans to repurchase shares worth between 50 million and 70 million yuan, with a maximum repurchase price of 10.07 yuan per share [24]

华神科技（000790）公告，子公司星瑞药业将持有的上海凌凯5.4019%股份以2亿元转让给陆茜，交易 完成后星瑞药业不再持有上海凌凯股份。 ...

证券代码：000790 证券简称：华神科技 公告编号：2025-017 成都华神科技集团股份有限公司 关于子公司出售参股公司股权的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 成都华神科技集团股份有限公司（以下简称"公司"）于 2025 年 5 月 6 日召开第十 三届董事会第二十一次会议，审议通过了《关于子公司出售参股公司股权的议案》，同意 公司子公司海南华神星瑞药业科技有限公司（以下简称"星瑞药业"）将持有的上海凌凯科 技股份有限公司（以下简称"上海凌凯"）5.4019%股份以人民币 2 亿元转让给陆茜，本次交 易完成后，星瑞药业不再持有上海凌凯股份。 2022 年 9 月 29 日公司召开第十二届董事会第二十四次会议，审议通过了《关于全资 子公司对外投资的议案》，具体内容详见公司于 2022 年 9 月 30 日在巨潮资讯网披露的《关 于全资子公司对外投资的公告》（公告编号 2022-051）。 2024 年 5 月 16 日公司召开第十三届董事会第十二次会议，审议通过了《关于签署< 补充协议>及<股东特殊权利之终止协议>的议案》， ...